Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

A unique case showed a rare combination of two types of lichen planus on the face.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Isotretinoin was not effective in treating facial lichen planopilaris.

The document explains various skin conditions and their treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

No treatment showed clear superiority for lichen planopilaris.

The patient had a severe itchy rash and hair loss in the armpits.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.